0000899243-16-011563.txt : 20160112
0000899243-16-011563.hdr.sgml : 20160112
20160112173033
ACCESSION NUMBER: 0000899243-16-011563
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160111
FILED AS OF DATE: 20160112
DATE AS OF CHANGE: 20160112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aldeyra Therapeutics, Inc.
CENTRAL INDEX KEY: 0001341235
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 131 HARTWELL AVENUE
STREET 2: SUITE 320
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-761-4904
MAIL ADDRESS:
STREET 1: 131 HARTWELL AVENUE
STREET 2: SUITE 320
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: Aldexa Therapeutics, Inc.
DATE OF NAME CHANGE: 20130102
FORMER COMPANY:
FORMER CONFORMED NAME: Neuron Systems Inc
DATE OF NAME CHANGE: 20051012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clark David J
CENTRAL INDEX KEY: 0001662693
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36332
FILM NUMBER: 161339513
MAIL ADDRESS:
STREET 1: 131 HARTWELL AVE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2016-01-11
1
0001341235
Aldeyra Therapeutics, Inc.
ALDX
0001662693
Clark David J
C/O ALDEYRA THERAPEUTICS, INC.
131 HARTWELL AVENUE, SUITE 320
LEXINGTON
MA
02421
0
1
0
0
Chief Medical Officer
/s/ David J. Clark
2016-01-12